ANASTROZOLE ERIS anastrozole 1 mg film-coated tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

anastrozole, Quantity: 1 mg

Verfügbar ab:

Strides Pharma Science Pty Ltd

INN (Internationale Bezeichnung):

Anastrozole

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: sodium starch glycollate; lactose monohydrate; hypromellose; magnesium stearate; povidone; titanium dioxide; macrogol 400

Verabreichungsweg:

Oral

Einheiten im Paket:

30 tablets

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

First line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to ANASTROZOLE ERIS.

Produktbesonderheiten:

Visual Identification: White to off-white, round, biconvex film coated tablet engraved with the letters "A 1" on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2012-09-24